Precision prevention is one of our strategic areas of focus. By studying cancer cell genetics, biological and environmental factors, we are developing novel approaches for life-saving cancer research.Steven D. Leach, MD
Everyone has different genetics, different environmental exposures and different values. Precision prevention takes all of those into account and then tailors a specific set of approaches, including behavior modification recommendations as well as screening and interventions, for each individual.
On Thursday, March 3, 2022, an expert medical panel will discuss the groundbreaking developments in precision prevention and cancer care at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC).
“At NCCC, we are taking full advantage of the recent launch of the Byrne Family Research Institute to elevate and accelerate our contributions among global cancer research institutes and to transform cancer treatment,” said Steven D. Leach, MD, director of NCCC, and moderator for the event. “Precision prevention is one of our strategic areas of focus. By studying cancer cell genetics, biological and environmental factors, we are developing novel approaches for life-saving cancer research. This work in precision medicine is leading us to new and innovative treatments that take into account an individual’s immune status, metabolism and specific microbiome along with the development and growth of a specific tumor. We literally are working to stop cancer before it gets started.”
- Bonnie W. Lau, MD, PhD, pediatric hematologist/oncologist at NCCC and associate professor of Pediatrics at the Geisel School of Medicine at Dartmouth.
- Brock C. Christensen, PhD, co-director of the Cancer Population Sciences program at NCCC and associate professor of Epidemiology at Geisel.
- Lisa A. Marsch, PhD, professor of Data Science at Geisel and director of the Dartmouth Center for Technology and Behavioral Health.
To register for the event, visit: https://dhmcalumdev.hitchcock.org/events/precision-prevention
About Norris Cotton Cancer Center
Norris Cotton Cancer Center, located on the campus of Dartmouth-Hitchcock Medical Center (DHMC) in Lebanon, NH, combines advanced cancer research at Dartmouth College’s Geisel School of Medicine in Hanover, NH with the highest level of high-quality, innovative, personalized, and compassionate patient-centered cancer care at DHMC, as well as at regional, multi-disciplinary locations and partner hospitals throughout NH and VT. NCCC is one of only 51 centers nationwide to earn the National Cancer Institute’s prestigious “Comprehensive Cancer Center” designation, the result of an outstanding collaboration between DHMC, New Hampshire’s only academic medical center, and Dartmouth College. Now entering its fifth decade, NCCC remains committed to excellence, outreach and education, and strives to prevent and cure cancer, enhance survivorship and to promote cancer health equity through its pioneering interdisciplinary research. Each year the NCCC schedules 61,000 appointments seeing nearly 4,000 newly diagnosed patients, and currently offers its patients more than 100 active clinical trials.